TY - JOUR
T1 - Comparison of Three Diagnostic Frameworks for Pyoderma Gangrenosum
AU - Haag, Carter
AU - Hansen, Trevor
AU - Hajar, Tamar
AU - Latour, Emile
AU - Keller, Jesse
AU - Shinkai, Kanade
AU - Ortega-Loayza, Alex G.
N1 - Funding Information:
AGOL is supported by Gerlinger Research Endowment and Medical Research Foundation of Oregon. Conceptualization: CH, TrH, TaH, JK, KS, AGOL; Data Curation: TrH, EL; Formal Analysis: EL; Investigation: TrH, JK, AGOL; Methodology: TaH, EL, JK, KS, AGOL; Project Administration: CH, AGOL; Resources: EL, JK, AGOL; Supervision: AGOL; Validation: JK, KS, AGOL; Visualization: CH, TrH, TaH, EL; Writing - Original Draft Preparation: CH, TrH, EL, AGOL; Writing - Review and Editing: CH, TrH, TaH, EL, JK, KS, AGOL
Publisher Copyright:
© 2020 The Authors
PY - 2021/1
Y1 - 2021/1
N2 - Pyoderma gangrenosum (PG) is an inflammatory condition characterized by chronic cutaneous ulcerations. There are three proposed PG diagnostic frameworks (Su, PARACELSUS, Delphi); however, they lack consensus, and their performance has not yet been validated in a well-defined cohort of patients with PG. In this cross-sectional retrospective cohort study, we sought to evaluate and compare the concordance of these diagnostic frameworks within a single-institution cohort of patients with PG. There were 47 patients from an initial 76 identified by International Classification of Diseases-9 and/or International Classification of Diseases-10 codes, where two PG experts agreed in their diagnosis of PG on the basis of clinical descriptions, photographs, and pathology. This group was the PG cohort by which we evaluated the performance and concordance of the diagnostic frameworks. The PARACELSUS score identified the highest proportion of patients with PG (89% [42 of 47 patients]), followed by Delphi and Su criteria, each at 74% (35 of 47 patients). Assessment of multirater agreement found that the three criteria agreed in their diagnoses for 72% of the patients (95% confidence interval = 60–85%); chance-adjusted agreement was determined to be 0.44 (95% confidence = 0.16–0.68, Fleiss’ kappa). Future research should seek to refine these diagnostic frameworks and identify targeted methods of testing to reduce rates of PG misdiagnosis and patient misclassification in clinical trials.
AB - Pyoderma gangrenosum (PG) is an inflammatory condition characterized by chronic cutaneous ulcerations. There are three proposed PG diagnostic frameworks (Su, PARACELSUS, Delphi); however, they lack consensus, and their performance has not yet been validated in a well-defined cohort of patients with PG. In this cross-sectional retrospective cohort study, we sought to evaluate and compare the concordance of these diagnostic frameworks within a single-institution cohort of patients with PG. There were 47 patients from an initial 76 identified by International Classification of Diseases-9 and/or International Classification of Diseases-10 codes, where two PG experts agreed in their diagnosis of PG on the basis of clinical descriptions, photographs, and pathology. This group was the PG cohort by which we evaluated the performance and concordance of the diagnostic frameworks. The PARACELSUS score identified the highest proportion of patients with PG (89% [42 of 47 patients]), followed by Delphi and Su criteria, each at 74% (35 of 47 patients). Assessment of multirater agreement found that the three criteria agreed in their diagnoses for 72% of the patients (95% confidence interval = 60–85%); chance-adjusted agreement was determined to be 0.44 (95% confidence = 0.16–0.68, Fleiss’ kappa). Future research should seek to refine these diagnostic frameworks and identify targeted methods of testing to reduce rates of PG misdiagnosis and patient misclassification in clinical trials.
UR - http://www.scopus.com/inward/record.url?scp=85087759326&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087759326&partnerID=8YFLogxK
U2 - 10.1016/j.jid.2020.04.019
DO - 10.1016/j.jid.2020.04.019
M3 - Article
C2 - 32445742
AN - SCOPUS:85087759326
SN - 0022-202X
VL - 141
SP - 59
EP - 63
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 1
ER -